Category: St. Jude Medical
St. Jude Medical says the FDA cleared the Sylmar, Calif., plant that produces its Durata defibrillators leads following a warning letter issued early last year.
Medtech titan Medtronic reveals that it and 2 other device makers suffered cybersecurity breaches last year.
Medtronic (NYSE:MDT) revealed today that it was the target of a digital attack sometime in 2013, seeming to confirm rumors that circulated earlier this year regarding a hack of some of the medtech's top players.
Medtronic unveils early results from the 1st patients implanted with the pill-sized Micra pacemaker and Sorin shows that its 'SafeR' mode of pacing prevents unnecessary shocks.
Here's a look at some of the top legal news stories for medical device companies this week: Appeals court upholds Gore win over St. Jude Medical; Independent legal panel rejects Infuse allegations in Medtronic shareholder suits; Judge dismisses Anulex from Xclose off-label lawsuit; Appeals court upholds Abiomed win in shareholder's class action; Convicted ex-Heart Tronics CEO won't get a retrial, judge rules.
Here's a look at some of the top Wall Street stories for medical device companies this week: Medtronic, Johnson & Johnson park billions in offshore accounts; Philips, Teva ink Israeli medtech incubator JV; Allergan board members unanimously reject Valeant's $53B offer; Convicted ex-Heart Tronics CEO won't get a retrial, judge rules.
, Heart Tronics
, Johnson & Johnson
, Pershing Capital Management
, Philips Healthcare
, Securities & Exchange Commission (SEC)
, St. Jude Medical
, Teva Pharmaceuticals
, Valeant Pharmaceuticals
, Abbott Laboratories
, Allergan Inc.
A federal appeals court upholds W.L. Gore & Assoc.'s win over St. Jude Medical in their patent spat over heart defect repair technology.
A federal appeals court today upheld a win for W.L. Gore & Assoc. in a patent war with St. Jude Medical (NYSE:STJ) over heart defect repair technology.
Some of medtech's largest players, including Medtronic, Johnson & Johnson and Abbott, rank high on the list of companies with the most money housed in offshore tax havens, according to a new report.
There are no awards handed out for companies with the most money housed in overseas accounts, but keeping cash in tax havens is its own reward for at least a dozen top medical device makers, according to a new study.